BioSpace News Archive

D-PLEX100 Administration into the Surgical Site Led to Statistically Significant Reduction in Infections Compared to Standard of Care Alone

Phase 2a studies of ABI-H0731 + nucleos(t)ide analogs (Nrtl) in HBeAg+ patients show faster and deeper declines in HBV DNA and RNA with combination than Nrtl alone, as well as subsequent declines in the surrogate markers of cccDNA with long-term treatment

Palatin Technologies, Inc. announced that data from two pivotal, double-blind placebo-controlled Phase 3 trials and the Exit Survey/Interview data on Vyleesi™ for hypoactive sexual desire disorder will be presented at the 13th European Society of Gynecology Conference in Vienna, Austria.

Appointment reinforces Armata’s commitment to develop Pseudomonas phage product candidates

Pyxis Oncology, an immuno-oncology company focused on developing a new family of antibody-based immunotherapies derived from novel insights into the biology of the tumor microenvironment, today announced the appointment of Ronald Herbst, PhD, as Chief Scientific Officer effective October 15, 2019.

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today confirmed that its Presentation at The MJ Micro Conference (the “Conference” or “MJ Micro”) will take place this afternoon between 1:00-1:30 pm PST

Novocure (NASDAQ: NVCR) today announced that results from the STELLAR trial were published in The Lancet Oncology.

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading provider of surgical services, today announced that the Company will release its third quarter 2019 results before the market opens on Tuesday, November 5, 2019, to be followed by a conference call at 8:30 a.m. (Eastern Time)

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2019.

West Health, a family of nonprofit, nonpartisan organizations focused on lowering the cost of healthcare to enable successful aging, has named Marie Kennedy as its chief communications officer.